Skip to content

Serotonin: all studies

Page 297 of 400: studies 2,961 to 2,970 of 3,999, newest first. Back to the serotonin overview

Research

Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice

ACS Chemical Neuroscience January 5, 2021 Mario de la Fuente Revenga, Urjita H. Shah, Nima Nassehi et al.

Known classic psychedelic serotonin 2A receptor (5-HT2AR) agonists retain a tryptamine or phenethylamine at their structural core. However, activation of the 5-HT2AR can be elicited by drugs lacking these fundamental scaffolds. Such is the case of the N-substituted piperazine quipazine. Here, we show that quipazine bound to and activated 5-HT2AR as measured by [3H]ketanserin binding...

Mindfulness-Based Cognitive Therapy in Major Depressive Disorder: A Study Protocol of a Randomized Control Trial and a Case-Control Study With Electroencephalogram.

Frontiers in Psychiatry 2021 Tianran Zhang, Lanlan Wang, Yanle Bai et al.

Background: In this report, a study protocol for a randomized control trial is presented in an attempt to explore the efficacy of mindfulness-based cognitive therapy (MBCT) for major depressive disorder (MMD), and a case-control study is conducted to find the difference in electroencephalograms (EEGs) between MMD and normal controls. Design: Seventy Chinese patients with MMD will be chosen for...

DOI: 10.3389/fpsyt.2021.499633 (opens in new tab) Full text (opens in new tab) Major depressive disorder Case-control study Electroencephalogram Randomized-control trial

Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up.

Frontiers in Psychiatry 2021 Tianran Zhang, Lu Lu, Fabrizio Didonna et al.

Background: This was the first randomized controlled trial (RCT) designed to compare the efficacy of mindfulness-based cognitive therapy (MBCT) on unmedicated obsessive-compulsive disorder with that of the first-line treatment for OCD (SSRIs) or a placebo, as well as to analyze the treatment acceptability and safety of MBCT. Methods: A total of 123 unmedicated OCD patients with mild to moderate...

Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.

Advances in experimental medicine and biology 2021 Rafael G. Dos Santos, Jaime E. C. Hallak, José Alexandre S. Crippa

Cannabis can synthetize more than 400 compounds, including terpenes, flavonoids, and more than 100 phytocannabinoids. The main phytocannabinoids are Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Cannabis-based products are used as medicines in several countries. In this text, we present an overview of the main neurochemical mechanisms of action of the phytocannabinoids, especially THC...

DOI: 10.1007/978-3-030-57369-0_3 (opens in new tab) Full text (opens in new tab) Endocannabinoids Mechanisms of action Neuropharmacology Phytocannabinoids

EL BOOM DE LA AYAHUASCA. A PROPÓSITO DE UN CASO. A PROPÓSITO DE UN CASO

Libro Comunicaciones 2021

La ayahuasca1 es una decocción tradicional amazónica con propiedades psicoactivas, se elabora a partir de la corteza de la vid Banisteriopsis caapi (que contiene alcaloides betacarbolina) y las hojas del arbusto Psychotria viridis (que suministra el alucinógeno N, N-dimetiltriptamina, DMT, que actúa como agonista serotoninérgico 5-HT2A). La ayahuasca se ha incorporado a la medicina popular y la...

Pharmacology and Neurotoxicity of 5-MeO-DIPT

Handbook of Neurotoxicity 2021 Krystyna Gołembiowska

Psychedelics are drugs that alter consciousness and affect human psyche. 5-Methoxy- N,N -diisopropyltryptamine (5-MeO-DIPT) emerged in the recreational drug market with the street name “foxy” and has been increasingly used as a substitute for methylenedioxymethamphetamine (MDMA) Methylenedioxymethamphetamine (MDMA) . 5-MeO-DIPT is a competitive inhibitor of the serotonin (5-HT) transporter...

An Overview of Alkaloids Derived from Tryptophan and Their Potential Antidepressant Action

Revista Virtual de Química 2021 Maria Emanuelle Damazio Lima, Isian Santos da Silva, Mariana de Oliveira Leal Desmarais et al. 2 citations

Most of the new developed drugs are natural or analogous products, including those that act on the Central Nervous System. The search for new drugs for the treatment of depression is increasing, in view of the high worldwide incidence of this mental disorder. In this context, tryptophan derivatives have an antidepressant effect due to the presence of indole rings, which give them a similarity...

DOI: 10.21577/1984-6835.20210055 (opens in new tab) Antidepressant Action physics Tryptophan Pharmacology +2

LSD em micropontos (estrelinhas) coloridos

Revista Criminalistica e Medicina Legal 2021 Luciano C Arantes, Bruno Leite, Luisa Ferreira 12 citations

A dietilamida do ácido lisérgico é uma das substâncias alucinógenas mais potentes já sintetizadas. Sua sigla, LSD, vem do alemão: Lysergsäurediethylamid. O LSD é sintetizado a partir do ácido lisérgico, produzido pelo fungo parasita esporão-do centeio (Claviceps purpurea), nome alusivo ao seu corpo de frutificação e ao principal cereal hospedeiro. O LSD tem afinidade por receptores...

Zebrafish and Artemia salina in vivo evaluation of the recreational 25C-NBOMe drug demonstrates its high toxicity.

Toxicology Reports 2021 Natalie Álvarez-alarcón, Jhon Jairo Osorio-Méndez, Adis Ayala-Fajardo et al. 26 citations

The NBOMe (N-2-methoxybenzyl-phenethylamines) family of compounds are synthetic hallucinogens derived from the 2C series. Although this family of compounds has been responsible for multiple cases of acute toxicity and several deaths around the world, to date there are few studies. These compounds act as potent 5-HT2A receptor agonists, including the hallucinogen 25C-NBOMe...

DOI: 10.1016/j.toxrep.2021.01.010 (opens in new tab) Full text (opens in new tab) 25c-nbome Artemia salina Teratogenic effects Toxicity +1

Psilocybin therapy appears as effective as escitalopram, small study finds

Pharmaceutical journal/˜The œpharmaceutical journal 2021

Psilocybin therapy appears to be at least as effective as escitalopram in treating depression, findings from a small phase II study published in the New England Journal of Medicine have indicated (15 April 2021)​[1]​. Researchers compared two sessions of psychedelic psilocybin therapy, delivered in a specialist clinical setting, with a course of the selective serotonin […]